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Abstract We have used DNase I footprinting to examine the
effect of a novel naphthylquinoline dimer, designed as a triplex-
specific bis-intercalator, on the stability of intermolecular DNA
triplexes. We find that this compound efficiently promotes
triplex formation between the 9-mer oligonucleotide 5P-
TTTTTTCTT and its oligopurine duplex target at concentra-
tions as low as 0.1 WM, enhancing the triplex stability by at least
1000-fold. This compound, which is the first reported example of
a triplex bis-intercalator, is about 30 times more potent than the
simple monofunctional ligand.
z 1999 Federation of European Biochemical Societies.
Key words: Triplex ligand; Footprinting; DNA triplex;
Bis-intercalator; Naphthylquinoline
1. Introduction
Intermolecular triple helices, which are formed by the se-
quence-speci¢c binding of an oligonucleotide in the major
groove of duplex DNA, have a potential use as antigen agents
for treating diseases such as cancer or viral infections [1^4].
The third strand bases form hydrogen bonds with substituents
on the purine bases of the duplex [5,6]. Pyrimidine-containing
third strands bind parallel to the duplex purine strand forming
CWGC and TWAT triplets [7,8].
Although third strand oligonucleotides bind to duplex
DNA with a high sequence speci¢city, the binding may not
be strong and is limited by charge repulsion between the three
poly-anions. Several strategies have been suggested for in-
creasing the triplex a⁄nity, including modi¢cation of the
backbone [9,10], bases [11^13] and sugar residues [14,15].
The binding a⁄nity can also be improved by tethering a
non-speci¢c DNA-binding agent such as acridine or psoralen
to either end of the third strand oligonucleotide [16^19]. An
alternative strategy is to develop compounds which bind spe-
ci¢cally to triplex, but not duplex, DNA. Several of such
agents have been described (see Fig. 1A) including the benzo-
pyridoindoles BePI (1) and BgPI [20,21], benzopyridoqui-
noxaline [22], benzoquinoquinoxaline [23] (2), dibenzophenan-
throlines [24] (3), coralyne (4) [25,26] and bis-substituted
anthraquinones (5) [27]. A further series of triplex-binding
ligands consists of substituted naphthylquinolines (6) which
also appear to bind by intercalation [28^30]. These com-
pounds possess a large aromatic area which can stack with
the three bases in the triplex, yet since the aromatic portions
are not fused they possess torsional £exibility and can accom-
modate the propeller twist of the triplets, in which the three
bases may not be coplanar.
The a⁄nity of duplex intercalators, such as acridine, has
been previously increased by tethering two or more together
using £exible linkers generating poly-intercalators [31]. In this
paper we have used DNase I footprinting to examine the
ability of a novel naphthylquinoline dimer (7) to stabilise
DNA triplexes and have compared its activity with a mono-
functional derivative (6).
2. Materials and methods
2.1. Chemicals and enzymes
Oligonucleotides were purchased from Oswel DNA service and
were stored at 320‡C in water. DNase I was purchased from Sigma
and stored at 320‡C at a concentration of 7200 U/ml. Reverse tran-
scriptase was purchased from Promega, restriction enzymes were pur-
chased from Promega, Pharmacia or New England Biolabs. The
naphthylquinoline triplex-binding ligand (6) (Fig. 1A) was prepared
as previously described [28]. Synthesis of the bis-naphthylquinoline (7)
will be described elsewhere. These compounds were stored as 20 mM
stock solutions in dimethylsulfoxide at 320‡C and diluted to working
concentrations in the appropriate bu¡er prior to use.
2.2. DNA fragments
The sequence of the 160 base pair tyrT fragment was modi¢ed by
PCR-mediated site-directed mutagenesis introducing a 17 base homo-
purine tract between positions 43 and 59 [32]. The sequence of the
oligopurine tract is shown in Fig. 1B. The 160 base pair fragment
tyrT(43-59) was obtained by digesting the plasmid with EcoR1 and
Sma1 and was labelled at the 3P end of the EcoR1 site with
[K32P]dATP using reverse transcriptase. The labelled fragment of in-
terest was separated from the remainder of the plasmid DNA on a 6%
non-denaturing polyacrylamide gel, eluted and dissolved in 10 mM
Tris-HCl, pH 7.5, containing 0.1 mM EDTA at a concentration of
about 10 cps/Wl (approximately 10 nM). This procedure labelled the
purine-containing strand of the triplex target site.
2.3. DNase I footprinting
Radiolabelled DNA (1.5 Wl) was mixed with 1.5 Wl oligonucleotide,
dissolved in an appropriate bu¡er and 1.5 Wl of triplex-binding ligand
or bu¡er. This mixture was left to equilibrate at 20‡C for at least 1 h.
Experiments were performed in 50 mM sodium acetate, pH 5.0, con-
taining 10 mM MgCl2. The mixture was then digested by adding 2 Wl
DNase I, diluted in 20 mM NaCl containing 2 mM MgCl2 and 2 mM
MnCl2, and stopped after 1 min by adding 3.5 Wl of a solution con-
taining 80% formamide, 10 mM EDTA and 0.1% (w/v) bromophenol
blue. Samples were boiled for 3 min before electrophoresis.
2.4. Gel electrophoresis
Products of DNase I digestion were separated on 10% (w/v) poly-
acrylamide gels containing 8 M urea which were run for about 2 h at
1500 V. Samples were heated to 100‡C for 3 min prior to electro-
phoresis. After about 2 h electrophoresis, the gels were ¢xed in 10%
(v/v) acetic acid, transferred onto Whatman 3 MM paper, dried under
vacuum at 80‡C for 1 h and subjected to autoradiography at 370‡C
with an intensifying screen. Bands in the digests were assigned by
comparison with Maxam-Gilbert dimethyl sulfate-piperidine markers
speci¢c for guanine.
2.5. Quantitative analysis
Autoradiographs of DNase I digestion patterns were scanned using
a Hoefer GS365 microdensitometer or analysed using a Molecular
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Dynamics STORM phosphorimager. For the densitometric analysis,
we chose a band in each site which was well resolved and cut well in
the control (ApG, position 53). The intensity of this band was esti-
mated using the manufacturers software and normalised with respect
to the intensity of two bands outside the target site (positions 38 and
61 or 69). For phosphorimage analysis we calculated the intensity of
bands within the entire footprint. It should be noted that in all con-
ditions the concentration of the third strand oligonucleotide is much
greater than that of the DNA target. As a consequence, the amount of
bound oligonucleotide will be determined by the equilibrium dissoci-
ation constant, rather than the stoichiometric ratio of third strand to
target. Footprinting plots [33] were constructed from these data and
C50 values, indicating the oligonucleotide concentration which re-
duced the band intensity by 50%, were derived by ¢tting a simple
binding curve to plots of the band intensity against the oligonucleo-
tide concentration using FigP for Windows (Biosoft). These were
¢tted to the equation Ic=I0U(C50/(L+C50) where Ic is the band inten-
sity in the presence of the ligand, I0 is the band intensity in the control
and L is the oligonucleotide concentration.
3. Results
We have previously shown that the 9-mer triplex-forming
oligonucleotide 5P-TTTTTTCTT binds very weakly to its tar-
get site in tyrT(43-59) (Fig. 1B) [34]. This weak interaction is
attributed to its short length and the large number of TWAT
triplets, with only one CWGC triplet [34,35]. The interaction
with this oligonucleotide alone is shown in the ¢rst panel of
Fig. 2 in which it can be seen that there are no oligonucleo-
tide-induced changes in the cleavage pattern at concentrations
as high as 30 WM, even at this low pH (5.0) in the presence of
10 mM MgCl2. As expected, the binding of this oligonucleo-
tide is potentiated by addition of the mono-naphthylquinoline
triplex-binding ligand (6). The fourth panel of this Figure
shows the e¡ect of varying oligonucleotide concentrations in
the presence of 3 WM of the monofunctional ligand (6). A
footprint, which is most clearly seen from the inhibition of
cleavage of the band at position 53, is now evident at the
target site, which persists to an oligonucleotide concen-
tration of about 0.4 WM. The footprinting plot shown in
Fig. 3A was generated from these data revealing that, in the
presence of 3 WM ligand the C50 value (which approximates to
the apparent dissociation constant of the oligonucleotide) is
0.31 WM. This is comparable with a value of 0.19 WM in the
presence of 10 WM of this ligand [34]. In the presence of lower
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Fig. 1. (A) Structures of several triplex-binding ligands. (1) BePI [20,21], (2) benzoquinoquinoxaline [23], (3) dibenzophenanthroline [24],
(4) coralyne [25,26], (5) bis-substituted anthraquinones, (6) monofunctional naphthylquinoline derivative [28^30] and (7) bifunctional naphthyl-
quinoline derivative. (B) Sequence of the 17 base pair oligopurine tract in tyrT(43-5) (boxed) together with the third strand 9-mer oligonucleo-
tide.
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concentrations of the ligand (not shown), larger oligonucleo-
tide concentrations are required to produce DNase I foot-
prints.
The second and third panels of Fig. 2 show similar DNase I
footprints performed in the presence of 0.5 WM and 0.1 WM of
the bis-naphthylquinoline ligand (7). At these low concentra-
tions, the ligand alone does not a¡ect the DNase I cleavage
pattern, though concentrations of 3 WM and above cause a
general non-speci¢c reduction in DNase I cleavage (not
shown), presumably as a result of the interaction with duplex
DNA. In the presence of 0.5 WM ligand (7), the footprint
persists to an oligonucleotide concentration of about
0.05 WM. A footprint is still evident with concentrations of
this ligand as low as 0.1 WM (third panel), persisting to an
oligonucleotide concentration of about 0.2 WM. Quantitative
analysis of these data produces the footprinting plots shown
in Fig. 3B which yield C50 values of 0.026 and 0.12 WM with
0.5 and 0.1 WM ligand, respectively. Inspection of these C50
values reveals that 0.1 WM bifunctional ligand (7) stabilises
triplexes to a greater extent than 3 WM of the monofunctional
derivative (6), consistent with the suggestion that it acts as a
triplex bis-intercalator.
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Fig. 2. DNase I cleavage patterns of tyrT(43-59) in the presence of varying concentrations of the 9-mer oligonucleotide 5P-TTTTTTCTT and
the naphthylquinoline triplex-binding ligands. The second and third panels (bis-naphthyl) were performed in the presence of the bifunctional de-
rivative (7), while the fourth panel (mono-naphthyl) included the monofunctional derivative (6). All reactions were performed in 50 mM sodium
acetate, pH 5.0, containing 10 mM MgCl2. The left hand panel shows digestion in the presence of the oligonucleotide without addition of the
triplex-binding ligands. Oligonucleotide concentrations (WM) are indicated at the top of each lane. Tracks labelled ‘con’ show digestion of the
DNA in the absence of added oligonucleotide or triplex-binding ligand. Tracks labelled ‘GA’ are Maxam-Gilbert markers speci¢c for purines.
The brackets indicate the position of the 9-mer target site. The bands are numbered according to the scheme used in previous publications
[32,34].
Fig. 3. Footprinting plots showing the interaction of the 9-mer oli-
gonucleotide with its target site in the presence of (A) 3 WM mono-
naphthylquinoline (6) (a), (B) 0.5 WM bis-naphthylquinoline (7) (a)
or 0.1 WM bis-naphthylquinoline (7) (b). The intensity of the foot-
print was determined from analysis of the gels shown in Fig. 2. The
ordinate shows the oligonucleotide concentration (WM), the abscissa
shows the relative band intensity (arbitrary units). The lines drawn
correspond to simple binding curves with C50 values of 0.31 WM for
3 WM mono-naphthylquinoline (6), 0.026 WM for 0.5 WM bis-naph-
thylquinoline and 0.12 WM for 0.1 WM bis-naphthylquinoline (7).
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4. Discussion
The results presented in this paper demonstrate that the
naphthylquinoline dimer (7) stabilises DNA triplexes at least
30 times more e¡ectively than the monofunctional compound
(6). The increased binding strength supports our suggestion
that this compound is a triplex bis-intercalator and is the ¢rst
report of such a compound. However, the present studies do
not conclusively demonstrate the mechanism of binding. As
well as simple bifunctional intercalation within the triplex, we
cannot discount the possibility that one of the chromophores
binds within the triplex grooves or interacts externally with
the duplex or triplex. Bis-intercalators have two clear advan-
tages over monofunctional derivatives. Firstly, as shown in
this paper, bis-intercalators have an increased binding a⁄nity
and so can be used at lower concentrations to facilitate triplex
formation, thereby reducing the incidence of unwanted side
e¡ects. In theory, the a⁄nity of an ideal bis-intercalator
should be the product of its monofunctional components,
i.e. a monofunctional compound with a Kd of 106/M might
produce a bifunctional compound with a Kd of 1012/M. Such
dramatic increases in binding are rarely achieved as there are
additional steric and entropic constraints which limit the af-
¢nity of the bifunctional compound. For e⁄cient bis-interca-
lation, the length and nature of the linker will need to be
optimised and further studies on such compounds are in prog-
ress. Secondly, we would expect that bis-intercalators should
be better able to discriminate between duplex and triple DNA.
For example, a monofunctional compound which binds to
triplexes 10 times better than to duplexes should yield a bi-
functional derivative with 100-fold discrimination.
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